Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials 16 Clinical Trials by Phase in E7 Countries 17 Clinical Trials in E7 Countries by Trial Status 18 Clinical Trials by Phase 19 In Progress Trials by Phase 20 Clinical Trials by Trial Status 21 Clinical Trials by End Point Status 22 Subjects Recruited Over a Period of Time 23 Clinical Trials by Sponsor Type 24 Prominent Sponsors 25 Top Companies Participating in Liver Fibrosis Therapeutics Clinical Trials 26 Prominent Drugs 27 Latest Clinical Trials News on Liver Fibrosis 28 Jan 11, 2016: Conatus Initiates Phase 2b ENCORE-NF Clinical Trial of Emricasan in Patients With NASH Fibrosis 28 Nov 30, 2015: Intercept Pharmaceuticals Initiates Phase 1 Study of INT-767, a Dual FXR and TGR5 Agonist 28 Clinical Trial Profile Snapshots 29 Appendix 104 Abbreviations 104 Definitions 104 Research Methodology 105 Secondary Research 105 About GlobalData 106 Contact Us 106 Disclaimer 106 Source 107

List of Tables Liver Fibrosis Therapeutics, Global, Clinical Trials by Region, 2016* 6 Liver Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Liver Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Liver Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Liver Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Liver Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13 Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16 Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Liver Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2016* 19 Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20 Liver Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Liver Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Liver Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24 Liver Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Liver Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Liver Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27 List of Figures Liver Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Liver Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Liver Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Liver Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Liver Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Liver Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13 Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Liver Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Liver Fibrosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16 Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Liver Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Liver Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19 Liver Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20 Liver Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Liver Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Liver Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24 Liver Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Liver Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Liver Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27 GlobalData Methodology 105

Gilead Sciences, Inc. Pfizer Inc. Virobay Inc. Merck & Co., Inc. F. Hoffmann-La Roche Ltd. Nitto Denko Corporation Galectin Therapeutics, Inc. C. H. Boehringer Sohn AG & Co. KG Bristol-Myers Squibb Company Conatus Pharmaceuticals Inc.